WO2007090527A2 - Agent de traitement capillaire oxydant comprenant un extrait de ginseng - Google Patents

Agent de traitement capillaire oxydant comprenant un extrait de ginseng Download PDF

Info

Publication number
WO2007090527A2
WO2007090527A2 PCT/EP2007/000662 EP2007000662W WO2007090527A2 WO 2007090527 A2 WO2007090527 A2 WO 2007090527A2 EP 2007000662 W EP2007000662 W EP 2007000662W WO 2007090527 A2 WO2007090527 A2 WO 2007090527A2
Authority
WO
WIPO (PCT)
Prior art keywords
amino
acid
cosmetic composition
composition according
cosmetic
Prior art date
Application number
PCT/EP2007/000662
Other languages
German (de)
English (en)
Other versions
WO2007090527A3 (fr
Inventor
Anja Reichert
Konstantin Goutsis
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP07703051A priority Critical patent/EP1986592A2/fr
Publication of WO2007090527A2 publication Critical patent/WO2007090527A2/fr
Publication of WO2007090527A3 publication Critical patent/WO2007090527A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Definitions

  • the invention relates to compositions which additionally comprise ginseng extract in a cosmetic carrier in addition to at least one oxidizing agent, a hair treatment method with this composition, and the use of these agents for reducing the hair damage caused by the oxidizing agent, skin aging, skin irritation and the decrease in skin elasticity.
  • Oxidative agents find a wide range of applications in hair cosmetics.
  • oxidizing agent-containing cosmetics are used in the context of the application form of a perm as a shape fixation.
  • oxidation dyes For the dyeing of keratin fibers, in particular of hair, furs and skins, the so-called oxidation dyes play a preferential role because of their intense colors and good fastness properties.
  • hair dyes contain oxidation dye precursors in a cosmetic carrier.
  • the oxidation dye precursors used are developer substances and coupler substances.
  • the developer components form the actual dyes under the influence of oxidizing agents or of atmospheric oxygen with one another or with coupling with one or more coupler components.
  • a particular developer substance can also form very different color shades by combination with different couplers. Nevertheless, it often fails to come with the help of a single developer substance to a variety of natural shades. In practice, therefore, a combination of different developer required components and coupler components to obtain a single, natural-looking color.
  • Good oxidation dye precursors must fulfill the following prerequisites in the first place: In the case of the oxidative coupling, they must form the desired color shades with sufficient intensity and authenticity. When used in hair dyes they should already have a good absorption on human hair at temperatures below 40 0 C, with no significant differences may exist between strained and freshly regrown hair (leveling ability). They should be resistant to light, heat and the influence of hair shampoos and chemical reducing agents, eg. B. against perming fluids. After all, they should not stain the scalp too much and above all, they should be harmless from a toxicological and dermatological point of view.
  • hair bleaches In addition to an oxidizing agent, hair bleaches usually contain bleach boosters that support the oxidative decolorization of the natural pigment melanin and thus improve the lightening result.
  • Disulfide bridges of the hair keratin are cleaved by the reductive acting wave agent of a permanent wave treatment. Oxidizing agent-containing fixative, make it possible to re-tie these disulfide bridges elsewhere after hair shaping and fix in this way the shape of the new hairstyle. '
  • the oxidative cosmetics do not affect exclusively the change in the target parameters aimed at within the respective application. Sometimes more, sometimes less, other cosmetic parameters can be adversely affected. On the one hand, these further parameters are assigned to the target substrate itself (here: the keratin-containing fiber), on the other hand, parameters of all other substrates are affected whose contact with the oxidative cosmetic can not be avoided in the course of use (here: the skin).
  • the target substrate here: the keratin-containing fiber
  • parameters of all other substrates are affected whose contact with the oxidative cosmetic can not be avoided in the course of use (here: the skin).
  • the possible damage to the hair structure, as well as a deterioration of the conditioning of the hair on the one hand and the irritation of the hair Skin and a loss of elasticity of the skin on the other hand are undesirable possible side effects.
  • gels Cosmetic carriers in gel form are perceived by the consumer as a particularly aesthetic form of offering.
  • the term "gel” is further characterized in "Faraday discussions of the Chemical Society, No. 57, 1974 (Gels and Gelling Processes), PJ. Flory, pages 7-18". Accordingly, gels are divided into 4 subgroups:
  • gels with lamellar ordering structures including gel mesophases, e.g. Surfactant gels, in particular soap gels.
  • transparent gels are also to be understood as described, for example, in US Pat. Nos. 3,101,300 and 3,101,301. These transparent gels are referred to as microemulsion gels.
  • a general definition of microemulsion gels is given in "Happi: Household Pers., Prod. Ind. 30 (1993), No. 2, pp. 58-64".
  • the gel should not necessarily but preferably be flowable and be characterized by a high intrinsic viscosity, i.e., these compositions appear relatively highly viscous under the influence of low shear forces, such as intrinsic weight, but may be applied using higher shear forces, e.g. stir very easily when stirred. It is particularly important that after mixing with an oxidative hair color causing aqueous oxidizing agent composition, the intrinsic viscosity of the dyeing is maintained and the ready dyeing can be easily distributed on the hair, but does not run off the hair and the scalp or the face stains.
  • gel-form cosmetics offer some performance advantages.
  • the production of creams i.a., C7W emulsions
  • Creams often thicken.
  • the gels preferably used as cosmetic carriers within the scope of the invention retain their once-adjusted viscosity over a relatively long period of time and are easier to distribute on the head hair.
  • Oxidative compositions containing at least one oxidizer and ginseng extract in a cosmetic carrier reduce the above-mentioned adverse side effects of conventional oxidative cosmetics.
  • the abovementioned combination of active ingredients can be incorporated particularly well into gelatinous cosmetic carriers and is particularly effective and easy to use.
  • Object of the present invention is therefore to reduce the above-mentioned side effects of oxidative cosmetics already during their use and a preferably to provide stable and effective application form of the active ingredients found as a solution to this problem.
  • a first object of the invention is a cosmetic agent which contains in a cosmetic carrier at least one oxidizing agent and ginseng extract.
  • cosmetic creams, emulsions, gels or surfactant-containing foaming solutions for example shampoos, foam aerosols or other preparations which are particularly suitable for use on the hair
  • cosmetic carriers are particularly suitable as cosmetic carriers.
  • the ingredients in a powdered or tablet-like formulation, which is dissolved in water before use.
  • a gelatinous cosmetic carrier is particularly preferred.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers are to be understood as meaning aqueous solutions containing from 0.1 to 70% by weight of a C 1 -C 4 -alkyl alcohol, in particular ethanol or isopropanol.
  • the compositions of the invention may additionally contain other organic solvents, such as methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2-propylene glycol. Preference is given to all water-soluble organic solvents.
  • the oxidizing agents according to the invention are different from atmospheric oxygen and have such an oxidation potential that makes it possible to link disulphide bridges within or between the proteins of the hair keratin, oxidatively lighten the natural color pigment melanin and / or to oxidize a developer-type oxidation dye precursor.
  • the oxidizing agent used is in particular hydrogen peroxide and / or at least one addition product thereof, in particular to inorganic or organic compounds, such as, for example, sodium perborate, sodium percarbonate, Magnesium percarbonate, sodium percarbamide, polyvinylpyrrolidone n H 2 O 2 (n is a positive integer greater than 0), urea peroxide and melamine peroxide in question.
  • inorganic or organic compounds such as, for example, sodium perborate, sodium percarbonate, Magnesium percarbonate, sodium percarbamide, polyvinylpyrrolidone n H 2 O 2 (n is a positive integer greater than 0), urea peroxide and melamine peroxide in question.
  • the cosmetic composition can also be applied to the hair together with a catalyst which activates the oxidation of the substrate, such as, for example, oxidation dye precursors.
  • a catalyst which activates the oxidation of the substrate such as, for example, oxidation dye precursors.
  • catalysts are e.g. Metal ions, iodides, quinones or certain enzymes.
  • Suitable metal ions are, for example, Zn 2+ , Cu 2+ , Fe 2+ , Fe 3+ , Mn 2+ , Mn 4+ , Li + , Mg 2+ , Ca 2+ and Al 3+ . Particularly suitable are Zn 2+ , Cu 2+ and Mn 2+ .
  • the metal ions can in principle be used in the form of any physiologically acceptable salt or in the form of a complex compound.
  • Preferred salts are the acetates, sulfates, halides, lactates and tartrates.
  • Suitable enzymes are e.g. Peroxidases that can significantly increase the effect of small amounts of hydrogen peroxide. Furthermore, such enzymes are suitable according to the invention, which generate in situ small amounts of hydrogen peroxide with the aid of atmospheric oxygen and in this way biocatalytically activate the oxidation of the dye precursors.
  • Particularly suitable catalysts for the oxidation of dye precursors are the so-called 2-electron oxidoreductases in combination with the specific substrates, e.g.
  • Alcohol oxidase and alcohol MeOH, EtOH
  • lactate oxidase and lactic acid and their salts
  • the oxidizing agent is preferably in an amount of 1, 0 to 15 wt .-%, in particular from 3.0 to 12.0 wt .-%, each based on the weight of the ready-to-use agent, in the inventive composition.
  • ginseng is understood to mean the root of a plant from the family Araliaceae of the genus Ginseng. These plants include, among others, the Araliacee Panax ginseng C.A. Meyer, the so-called real ginseng, as well as Panax japonicus and Panax pseudoginseng.
  • the ginseng extract contains at least one sapogenin.
  • sapogenins which are selected from at least one compound of the formula (I) and / or at least one glycosidic derivative thereof
  • R 1 and R 2 independently represent a hydrogen atom or a hydroxy group.
  • the carbohydrate moiety will bind to one of the hydroxy groups of the molecule of formula (I).
  • the glycosidic derivatives of the compounds of the formula (I) are preferably derived from glucopyranose, arabinopyranose, arabinofuranose, xylofuranose, xylopyranose and / or rhamnopyranose. In each case L- or D-stereomers are possible.
  • glycosidic derivatives of the compounds of the formula (I) are particularly preferably derived from D-glucopyranose, L-arabinopyranose, L-arabinofuranose, D-xylofuranose, D-xylopyranose and / or L-rhamnopyranose.
  • Particularly preferred compounds of the formula (I) or their glycosidic derivatives are betulafolientriol, protopanaxadiol and / or protopanaxatriol.
  • ginseng As usable extracts of ginseng are for example the commercial products Extrapone ® ginseng (INCI name: Aqua (Water), ethoxydiglycol, Propylene Glycol, Butylene Glycol, Panax Ginseng Root Extract, Lactic Acid, glucose) from the company Symrise or Nova Plant ® ginseng (INCI Name: Aqua (Water), Butylene Glycol, Panax Ginseng Root Extract) from Crodarom.
  • a particularly preferred ginseng extract is sold by Cosmetochem under the trade name Herbasol® extract ginseng (INCI name: isopropyl myristate, Panax ginseng root extract) as an oil-soluble ginseng extract.
  • compositions according to the invention in which at least one protein or protein hydrolyzate, selected from at least one member of the group formed from pea protein, soy protein, almond protein, acacia protein, collagen and keratin and their hydrolyzates, is contained.
  • the agent according to the invention additionally contains at least one color-changing component.
  • the color-changing component is again preferably selected
  • the developer components are usually primary aromatic amines having a further, in the para or ortho position, free or substituted hydroxy or amino group, diaminopyridine derivatives, heterocyclic hydrazones, 4-amino pyrazole derivatives and 2,4,5,6-tetraaminopyrimidine and its Derivatives used.
  • p-phenylenediamine derivatives of the formula (Ent1) it may be preferred according to the invention to use as the developer component a p-phenylenediamine derivative or one of its physiologically acceptable salts. Particular preference is given to p-phenylenediamine derivatives of the formula (Ent1)
  • G 1 is a hydrogen atom, a C 1 to C 4 alkyl radical, a C 1 to C 4
  • Monohydroxyalkyl radical a C 2 - to C 4 -polyhydroxyalkyl radical, a (C 1 - to C 4 ) -
  • G 2 is a hydrogen atom, a C 1 - to C 4 -alkyl radical, a C 1 - to C 4 -
  • Monohydroxyalkyl radical a C 2 - to C 4 -polyhydroxyalkyl radical, a (C 1 - to C 4 ) -
  • G 3 represents a hydrogen atom, a halogen atom such as a chlorine, bromine, iodine or
  • Fluorine atom a C 1 to C 4 alkyl radical, a C 1 to C 4 monohydroxyalkyl radical, a
  • G 4 represents a hydrogen atom, a halogen atom or a C 1 - to C 4 -alkyl radical or, when G 3 and G 4 are ortho to each other, they may together form a bridging ⁇ , ⁇ -alkylenedioxy group, such as, for example, an ethylenedioxy group ,
  • Examples of the C 1 - to C 4 -alkyl radicals mentioned as substituents in the compounds according to the invention are the groups methyl, ethyl, propyl, isopropyl and butyl. Ethyl and methyl are preferred alkyl radicals.
  • C 1 -C 4 -alkoxy radicals preferred according to the invention are, for example, a methoxy or an ethoxy group.
  • a C 1 to C 4 hydroxyalkyl group there may be mentioned a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group.
  • a 2-hydroxyethyl group is particularly preferred.
  • a particularly preferred C 2 to C 4 polyhydroxyalkyl group is the 1, 2-dihydroxyethyl group.
  • halogen atoms are according to the invention F, Cl or Br atoms, Cl atoms are very particularly preferred. The other terms used are derived according to the invention from the definitions given here.
  • nitrogen-containing groups of the formula (Ent1) are in particular the amino groups, C 1 to C 4 monoalkylamino groups, C 1 to C 4 dialkylamino groups, C 1 to C 4 trialkylammonium groups, C 1 to C 4 monohydroxyalkylamino groups, Imidazolinium and ammonium.
  • Particularly preferred p-phenylenediamines of the formula (Ent1) are selected from p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2 , 6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N, N-dipropyl-p-phenylenediamine, 4 -Amino-3-methyl- (N, N-diethyl) -aniline, N, N-bis- ( ⁇ -hydroxyethyl) -p-phenylenediamine, 4-N, N-bis- ( ⁇ -hydroxyethyl) amino-2- methylaniline, 4-N,
  • p-phenylenediamine derivatives of formula (Ent1) are p-phenylenediamine, p-toluenediamine, 2- (ß-hydroxyethyl) -p-phenylenediamine, 2- ( ⁇ , ⁇ -dihydroxyethyl) -p-phenylenediamine and N, N-bis- ( ⁇ -hydroxyethyl) -p-phenylenediamine.
  • developer component compounds which contain at least two aromatic nuclei which are substituted by amino and / or hydroxyl groups.
  • binuclear developer components that can be used in the compositions according to the invention, mention may be made in particular of the compounds which correspond to the following formula (Ent2) and their physiologically tolerated salts:
  • Z 1 and Z 2 independently of one another, are a hydroxyl or NH 2 radical, which, by a C 1 is optionally substituted by a Ci to C4 alkyl group - is / or substituted hydroxyalkyl radical, and by a bridge Y, or - to C 4 which is optionally part of a bridging ring system, the bridge Y is an alkylene group having 1 to 14 carbon atoms, such as a linear or branched alkylene chain or an alkylene ring, which is one or more nitrogen-containing groups and / or one or more heteroatoms such as oxygen, Sulfur or nitrogen atoms may be interrupted or terminated and may be optionally substituted by one or more hydroxyl or C 1 - to C 8 -Al koxyreste, or a direct bond, G 5 and G 6 are independently a hydrogen or halogen atom , a C 1 - to C 4 -alkyl radical, a C 1 - to C 4 -monohydroxyalky
  • the compounds of formula (Ent2) contain at least one amino group which carries at least one hydrogen atom.
  • Preferred binuclear developer components of the formula (Ent2) are in particular: N, N'-bis ( ⁇ -hydroxyethyl) -N, N- l bis (4'-aminophenyl) -1,3-diamino-propan-2-ol, N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4 l -aminophenyl) ethylenediamine, N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis - ( ⁇ -hydroxyethyl) -N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis (4-methylaminophenyl) tetramethylenediamine, N 1 N 1 - diethyl-N, N ' bis (4'-amino-3'-methylphenyl) ethylenediamine, bis (2-hydroxy-5-aminophenyl) me
  • Very particularly preferred binuclear developer components of the formula (Ent 2) are N, N'-bis ( ⁇ -hydroxyethyl) -N, N 1 -bis (4'-aminophenyl) -1,3-diamino-propan-2-ol, Bis (2-hydroxy-5-aminophenyl) methane, 1, 3-bis (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4'-aminophenyl) -1, 4-diazacycloheptane and 1, 10-bis- (2 ', 5'-diaminophenyl) -1, 4, 7, 10-tetraoxadecane or one of their physiologically acceptable salts.
  • p-aminophenol derivatives of the formula (Ent3) in which:
  • G 13 represents a hydrogen atom, a halogen atom, a C 1 to C 4 alkyl radical, a C 1 to C 4 monohydroxyalkyl radical, a C 2 to C 4 polyhydroxyalkyl radical, a
  • G 14 represents a hydrogen or halogen atom, a C 1 - to C 4 -alkyl radical, a
  • C 1 - to C 4 monohydroxyalkyl radical a C 2 - to C 4 polyhydroxyalkyl radical, a (C 1 - to C 4) alkoxy (C r to C 4) alkyl group, a C 1 - to C 4 -aminoalkyl or a C 1 to C 4 cyanoalkyl radical,
  • G 15 is hydrogen, a C 1 - to C 4 -alkyl radical, a C 1 - to C 4 -
  • Monohydroxyalkyl radical a C 2 to C 4 polyhydroxyalkyl radical, a phenyl radical or a benzyl radical, and
  • G 16 is hydrogen or a halogen atom.
  • Preferred p-aminophenols of the formula (Ent3) are, in particular, p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4 -Amino-3-hydroxymethylphenol, 4-amino-2- ( ⁇ -hydroxyethoxy) -phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethyl-phenol, 4-amino 2-aminomethylphenol, 4-amino-2- ( ⁇ -hydroxyethyl-aminomethyl) phenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2 chlorophenol, 4-amino-2,6-dichlorophenol, 4-amino-2- (diethylaminomethyl) phenol and their physiologically acceptable salts.
  • Very particularly preferred compounds of the formula (Ent3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) phenol and 4-amino 2- (diethylaminomethyl) -phenol.
  • the developer component may be selected from o-aminophenol and its derivatives such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.
  • the developer component may be selected from heterocyclic developer components such as the pyridine, pyrimidine, pyrazole, pyrazole pyrimidine derivatives and their physiologically acceptable salts.
  • Preferred pyridine derivatives are, in particular, the compounds described in the patents GB 1 026 978 and GB 1 153 196, such as 2,5-diamino-pyridine, 2- (4'-methoxyphenyl) amino-3-amino-pyridine, 2,3-diamino-6-methoxy-pyridine, 2- ( ⁇ -
  • Methoxyethyl amino-3-amino-6-methoxy-pyridine and 3,4-diamino-pyridine.
  • Preferred pyrimidine derivatives are, in particular, the compounds described in German Patent DE 2 359 399, Japanese Laid-Open Patent Publication JP 02019576 A2 or in the published patent application WO 96/15765, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy- 2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6- triaminopyrimidine.
  • Preferred pyrazole derivatives are, in particular, the compounds described in patents DE 3 843 892, DE 4 133 957 and patent applications WO 94/08969, WO 94/08970, EP-740 931 and DE 195 43 988, such as 4,5 Diamino-1-methylpyrazole, 4,5-diamino-1 - ( ⁇ -hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1- (4'-chlorobenzyl) pyrazole, 4.5- Diamino-1, 3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-Benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl
  • Preferred pyrazolopyrimidine derivatives are, in particular, the derivatives of the pyrazolo [1,5-ajopyrimidine of the following formula (Ent4) and its tautomeric forms, if a tautomeric equilibrium exists:
  • G 17 , G 18 , G 19 and G 20 independently of one another represent a hydrogen atom, a C 1 - to C 4 -alkyl radical, an aryl radical, a C 1 - to C 4 -hydroxyalkyl radical, a C 2 - to C 4 polyhydroxyalkyl a (C 1 - to C 4 ) alkoxy (C r to C 4 ) alkyl, a Ci to C 4 -Aminoalkylrest, which may optionally be protected by an acetyl-ureide or a sulfonyl radical a (C 1 - to C 4) alkylamino (Ci to C 4) - alkyl group, a di - [(C r to C 4) alkyl] - (Ci to C4) aminoalkyl radical, wherein the Dialkyl radicals optionally form a carbon cycle or a heterocycle with 5 or 6 chain members, a C 1 - to C 4 -hydroxyalkyl-
  • pyrazolo [1, 5-a] pyrimidines of the above formula (Ent4) can be prepared as described in the literature by cyclization from an aminopyrazole or hydrazine.
  • m-phenylenediamine derivatives naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives and heterocyclic compounds are generally used.
  • Preferred coupler components according to the invention are m-aminophenol and its derivatives, such as, for example, 5-amino-2-methylphenol, N-cyclopentyl-3-aminophenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2 6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5- (2'- Hydroxyethyl) -amino-2-methylphenol, 3- (diethylamino) -phenol, N-cyclopentyl-3-aminophenol, 1,3-dihydroxy-5- (methylamino) -benzene, 3-ethylamino-4-methylphenol and 2,4 dichloro-3-aminophenol,
  • o-aminophenol and its derivatives m-diaminobenzene and its derivatives such as, for example, 2,4-diaminophenoxyethanol, 1,3-bis- (2 ', 4'-diaminophenoxy) -propane, 1-methoxy-2-amino- 4- (2'-hydroxyethylamino) benzene, 1,3-bis (2 ', 4'-diaminophenyl) -propane, 2,6-bis (2'-hydroxyethylamino) -1-methylbenzene, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -4-methoxy-5-methylphenyl ⁇ amino) ethanol, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -2-methoxy-5-methylphenyl ⁇ amino) ethanol, 2 - ( ⁇ 3 - [(2-hydroxyethyl) amino] -2-methoxy-5-methylphenyl ⁇ amino)
  • o-diaminobenzene and its derivatives such as 3,4-diaminobenzoic acid and 2,3-diamino-1-methylbenzene,
  • Di- or trihydroxybenzene derivatives such as resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4-trihydroxybenzene, Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4 dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine, naphthalene derivatives such as 1-naphthol, 2- Methyl 1-naphthol, 2-hydroxy
  • Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-aminobenzomorpholine,
  • Quinoxaline derivatives such as 6-methyl-1,2,3,4-tetrahydroquinoxaline, pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one, indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole, pyrimidine derivatives such as For example, 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine, 2-amino-4-hydroxy 6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or
  • Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1- (2'-hydroxyethyl) amino-3,4-methylenedioxybenzene and their physiologically acceptable salts.
  • coupler components according to the invention are 1-naphthol, 1, 5, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol , 2-chloro-6-methyl-3-aminophenol, 2-methyl resorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine and the physiologically acceptable salts of the abovementioned compounds.
  • the cosmetic agents contain the developer components preferably in an amount of 0.005 to 10 wt .-%, preferably from 0.1 to 5 wt .-%, each based on the total agent.
  • the cosmetic compositions contain the coupler components preferably in an amount of 0.005 to 10 wt .-%, preferably from 0.1 to 5 wt .-%, each based on the total agent.
  • the agent can be used as color-modifying component in the form of Oxofarbstoffvor pas at least one combination of at least one compound of the component
  • Compounds according to the invention having a reactive carbonyl group have at least one carbonyl group as reactive group which reacts with the compounds of component 2 to form a chemical bond linking both components. Further, according to the invention, those compounds are also included as component 1 in which the reactive carbonyl group is derivatized or masked in such a way that the reactivity of the carbon atom of the derivatized or masked carbonyl group with respect to the component 2 is always present.
  • These derivatives are preferably condensation compounds of reactive carbonyl compounds with a) amines and their derivatives to form imines or oximes as a condensation compound b) alcohols to form acetals or ketals as a condensation compound c) water to form hydrates as a condensation compound of aldehydes.
  • Component 1 is preferably selected from the group formed from acetophenone, propiophenone, 2-hydroxyacetophenone, 3-hydroxyacetophenone, 4-hydroxyacetophenone, 2-hydroxypropiophenone, 3-hydroxypropiophenone, 4-hydroxypropiophenone, 2-hydroxybutyrophenone, 3-hydroxybutyrophenone, 4-hydroxybutyrophenone, 2,4-dihydroxyacetophenone, 2,5-dihydroxyacetophenone, 2,6-dihydroxyacetophenone, 2,3,4-trihydroxyacetophenone, 3,4,5-trihydroxyacetophenone, 2,4,6-trihydroxyacetophenone non, 2,4,6-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone diethyl ketal, 4-hydroxy-3-methoxy-acetophenone, 3,5-dimethoxy-4-hydroxyacetophenone, 4-aminoacetophenone, 4-dimethylaminoacetophenone, 4- Morp
  • CH-acidic compounds are generally considered to carry a bound to an aliphatic carbon atom hydrogen atom, wherein due to electron-withdrawing substituents activation of the corresponding carbon-hydrogen bond is effected.
  • CH-acidic compounds also include enamines which are formed by alkaline treatment of quaternized N-heterocycles with a CH-acidic alkyl group in conjugation with the quaternary nitrogen.
  • the CH-acidic compounds of component 2 are preferably selected from the group consisting of 1, 2,3,3-tetramethyl-3H-indolium iodide, 1, 2,3,3-tetramethyl-3H-indolium p-toluenesulfonate, 1, 2,3,3-tetramethyl-3H-indolium methanesulfonate, 1,3,3-trimethyl-2-methylenindoline (Fischer's base), 2,3-dimethylbenzothiazolium iodide, 2,3-dimethylbenzothiazolium-p- toluenesulfonate, 2,3-dimethyl-naphtho [1,2-d] thiazolium p-toluenesulfonate, 3-ethyl-2-methyl-naphtho [1,2-d] thiazolium p-toluenesulfonate, rhodanine, rhodanine-3 acetic
  • Preferred primary or secondary aromatic amines of component 2 are selected from N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N- (2-hydroxyethyl) -N-ethyl-p-phenylenediamine, N, N- Bis (2-hydroxyethyl) -p-phenylenediamine, N- (2-methoxyethyl) -p-phenylenediamine, 2,3-dichloro-p-phenylenediamine, 2,4-dichloro-p-phenylenediamine, 2,5-dichloro p-phenylenediamine, 2-chloro-p-phenylenediamine, 2,5-dihydroxy-4-morpholinoaniline, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminomethyl-4-aminophenol, 2-hydroxymethyl-4- aminophenol, o-phenylenediamine, m
  • R 7 represents a hydroxy or an amino group represented by C 1-4 -alkyl, C 1-4 -hydroxyalkyl, C 1-4 -alkoxy or C 1-4 -alkoxy-Ci. 4- alkyl groups may be substituted,
  • R 8 , R 9 , R 10 , R 11 and R 12 independently of one another represent a hydrogen atom, a hydroxy or an amino group represented by C 1 -C 4 -alkyl, C 1 -C -hydroxyalkyl, C 1 -C 4 - Alkoxy, C r C 4 -Aminoalkyl- or C 1 -C 4 alkoxy-C 1 -C 4 alkyl groups may be substituted, and
  • P is a direct bond, a saturated or unsaturated, optionally substituted by hydroxyl groups carbon chain having 1 to 4 carbon atoms, a carbonyl, sulfoxy, sulfonyl or imino group, an oxygen or sulfur atom, or a group having the formula III
  • Q signifies a direct bond, a CH 2 or CHOH group
  • Q 'and Q "independently represent an oxygen atom, an NR 13 group, wherein R 13 represents a hydrogen atom, a C 1-4 alkyl or a hydroxy C 1-4 alkyl group, both of which together with the remainder of the molecule can form a 5-, 6- or 7-membered ring, the group O- (CH 2 ) p -NH or NH- (CH 2 ) p -O, where p and p 1 are 2 or 3, stand and
  • O is a number from 1 to 4,
  • the abovementioned compounds can be used both in free form and in the form of their physiologically acceptable salts, in particular as salts of inorganic acids, such as hydrochloric or sulfuric acid.
  • Suitable nitrogen-containing heterocyclic compounds are, for. B. 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 2-amino-3-hydroxy-pyridine, 2,6-diamino-pyridine, 2,5-diamino-pyridine, 2- (aminoethylamino) -5-aminopyridine, 2,3-diamino-pyridine, 2-dimethylamino-5-amino-pyridine, 2-methylamino-3-amino-6-methoxy-pyridine, 2,3-diamino-6-methoxy-pyridine, 2,6- Dimethoxy-3,5-diamino-pyridine, 2,4,5-triamino-pyridine, 2,6-dihydroxy-3,4-dimethylpyridine, N- [2- (2,4-diaminophenyl) aminoethyl] -N - (5-amino-2-pyridyl) -amine, N- [2- (4-
  • the hydroxypyrimidines disclosed in DE-U 1-299 08 573 can be used according to the invention.
  • the aforementioned compounds can be used both in free form and in the form of their physiologically acceptable salts, for. B. as salts of inorganic acids, such as hydrochloric or sulfuric acid, are used.
  • Suitable aromatic hydroxy compounds are, for.
  • the compounds of component 1 and the compounds of component 2 are preferably used in the cosmetic compositions in each case in an amount of 0.03 to 65 mmol, in particular from 1 to 40 mmol, based on 100 g of the total Nuancierstoffs used.
  • the molar ratio of the compound of component 1 and the compound of component 2 may range from 0.5 to 2.0, preferably using equimolar amounts.
  • the ready-to-use agent is prepared by separate mixing of components 1 and 2 immediately prior to application.
  • oxidation dye precursor of the developer type such indoles and indolines which have at least one hydroxyl or amino group, preferably as a substituent on the six-membered ring. These groups may carry further substituents, e.g. Example in the form of etherification or esterification of the hydroxy group or alkylation of the amino group.
  • the colorants contain at least one indole and / or indoline derivative.
  • Particularly suitable precursors of natural-analogous hair dyes are derivatives of 5,6-dihydroxyindoline of the formula (IVa), in the independently of each other
  • R 1 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C -hydroxy-alkyl group,
  • R 2 is hydrogen or a -COOH group, where the -COOH group may also be present as a salt with a physiologically compatible cation
  • R 3 is hydrogen or a C 1 -C 4 -alkyl group
  • R 4 is hydrogen, a C ⁇ C ⁇ alkyl group or a group -CO-R 6 in which R 6 represents a CrC t -alkyl group, and R 5 represents one of the groups mentioned for R 4, and physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • Particularly preferred derivatives of indoline are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6 dihydroxyindoline, 5,6-dihydroxyindoline-2-carboxylic acid and 6-hydroxyindoline, 6-aminoindoline and 4-aminoindoline.
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5, 6-Dihydroxyindolin.
  • R 1 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C 4 -hydroxyalkyl group
  • R 2 is hydrogen or a -COOH group, wherein the -COOH group may also be present as a salt with a physiologically compatible cation,
  • R 3 is hydrogen or a C 1 -C 4 -alkyl group
  • R 4 is hydrogen, a C 1 -C 4 alkyl group or a group -CO-R 6 in which R 6 represents a -C 4 alkyl group, and
  • R 5 represents one of the groups mentioned under R 4 , - and physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • Particularly preferred derivatives of indole are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5, 6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.
  • N-methyl-5,6-dihydroxyindole N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, and especially the 5,6 -Dihydroxyindol.
  • Preferred substantive dyes which are used in the cosmetic compositions as a color-changing component are nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • Preferred substantive dyes are those having the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1 , 4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis- ( ⁇ -hydroxyethyl) amino
  • the cosmetic agents may contain a cationic substantive dye. Particularly preferred are
  • Preferred cationic substantive dyes of group (c) are in particular the following compounds:
  • the compounds of the formulas (DZ1), (DZ3) and (DZ5) which are also known by the names Basic Yellow 87, Basic Orange 31 and Basic Red 51, are very particularly preferred cationic substantive dyes of group (c).
  • the cationic direct dyes which are sold under the trademark Arianor ® are, according to the invention also very particularly preferred cationic direct dyes.
  • the cosmetic compositions contain the substantive dyes preferably in an amount of 0.01 to 20 wt .-%, based on the ready-to-use agent.
  • compositions according to the invention may also naturally occurring dyes such as henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, seder and alkano root are included.
  • naturally occurring dyes such as henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, seder and alkano root are included.
  • oxidation dye precursors or the direct dyes it is not necessary for the oxidation dye precursors or the direct dyes to be in each case homogeneous compounds. Rather, in the cosmetic products, due to the production processes for the individual dyes, minor amounts of other components may be included, as far as they do not adversely affect the dyeing result or for other reasons, e.g. toxicological, must be excluded.
  • the actual oxidative color changing agent is prepared by separate storage of the dye precursors or the bleach booster and the oxidizing agent immediately before use by mixing.
  • the cosmetic agent is therefore mixed before application from a composition comprising at least one color-modifying component in a cosmetic carrier and a further composition containing at least one oxidizing agent in a cosmetic carrier.
  • the ready-to-use preparation is expediently prepared immediately before use by mixing a composition 1 comprising, in a cosmetic carrier, the oxidizing agent with the composition 2 containing the color-changing components in a cosmetic carrier.
  • the resulting ready-to-use hair preparation should preferably have a pH in the range from 6 to 12, in particular from pH 7.5 to 10.
  • the ginseng extract is preferably contained in the composition 1.
  • At least one bleaching booster is preferably used in the cosmetic compositions according to the invention.
  • Bleach boosters are preferably used in bleaching agents for increasing the bleaching action of the oxidizing agent, in particular the hydrogen peroxide.
  • bleach amplifiers it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid.
  • Suitable substances are those which carry O- and / or N-acyl groups of the stated C atom number and / or optionally substituted benzoyl groups.
  • polyacylated alkylenediamines in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N-acylimides, in particular N-nonanoylsuccinimide (NOSI) 1 acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate and 2,5- Diacetoxy-2,5-dihydrofuran.
  • TAED tetraacetyl
  • carbonate salts or bicarbonate salts can preferably be used according to the invention. These are preferably selected from the group of ammonium, alkali (especially sodium and potassium), and alkaline earth (especially calcium), carbonate salts or bicarbonate salts. Particularly preferred carbonate or bicarbonate salts are ammonium bicarbonate, ammonium carbonate, sodium bicarbonate, disodium carbonate,
  • Potassium bicarbonate dipotassium carbonate and calcium carbonate. These particularly preferred salts can be used alone or in their mixtures of at least two representatives as bleaching amplifiers.
  • At least one carbonic acid monoester and / or at least one carbonic acid monoamide are preferably used in the process according to the invention.
  • Preferred carbonic acid monoesters are the carbonic acid monoesters of the formula (V),
  • each O is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a C 1-6 alkyl group.
  • the groups are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • compositions particularly preferably used according to the invention are characterized in that the radical R in formula (V) is selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, terf-butyl - As well as hydroxymethyl and Hyd roxyethy I residues.
  • carbonic acid monoamides can be used as bleach boosters in the anhydrous compositions.
  • R is a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical, or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle.
  • R preferably represents a substituted or unsubstituted, straight-chain or branched alkyl, alkenyl or alkynyl radical, preference being given to hydroxy, amino, nitro, sulfonic acid groups or halogens as substituents.
  • Further preferred radicals R are phenyl and benzyl radicals and further substituted representatives. More preferably, R is a C 1-6 alkyl group.
  • C 1 -C 6 -alkyl groups are the groups methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl and hexyl.
  • Bleach enhancers of the formula (VI) which are particularly preferred according to the invention are characterized in that the radical R in formula (VI) is selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, isobutyl , tert-butyl and hydroxymethyl and hydroxyethyl radicals.
  • the acidic H atom of the carbonic acid monoester or monoamide can also be present in neutralized form, ie according to the invention it is also possible to use salts of carbonic acid monoesters or carbonic acid monoamides.
  • At least one silyl carbonate and / or at least one silyl carbamate are preferably incorporated into the compositions according to the invention.
  • radicals R 1 , R 2 and R 3 independently of one another represent a hydrogen atom, a saturated or unsaturated, straight-chain, branched or cyclic, substituted or unsubstituted hydrocarbon radical or a trialkylsilyl group, preferably a trimethylsilyl group or a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle or a halogen, a substituted or unsubstituted hydroxy, oxo, amino groups and the radical R 4 is a chemical bond to the Si atom or one of the radicals R 1 , R 2 or R 3 , is a hydrogen atom, a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical or a substituted or unsubstituted SiIyI or Aluminylrios or a substituted or unsubstituted aryl group or a substituted or unsubstit
  • Preferred radicals R 1 , R 2 and R 3 in the abovementioned formula (VII) are substituted or unsubstituted, straight-chain or branched alkyl radicals.
  • the alkyl groups having 1 to 5 carbon atoms and the hydroxyalkyl groups are preferred, so that preferred anhydrous compositions of the present invention are characterized in that the radicals R 1 , R 2 and R 3 in formula (VII) are selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, isobutyl, tert-butyl Butyl and hydroxymethyl and hydroxyethyl radicals.
  • Preferred radicals R 4 in the abovementioned formula (VII) are hydrogen, substituted or unsubstituted, straight-chain or branched alkyl radicals and trialkylsilyl radicals. Among them, preferred are hydrogen, methyl, ethyl, tert-butyl and trimethylsilyl radicals.
  • At least one silyl carbamate of the formula (VIII) may be present in the anhydrous composition according to the invention.
  • radicals R 1 , R 2 and R 3 independently of one another represent a hydrogen atom, a saturated or unsaturated, straight-chain, branched or cyclic, substituted or unsubstituted hydrocarbon radical or for a trialkylsilyl group, preferably a trimethylsilyl group or for a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocycle or a halogen, a substituted or unsubstituted hydroxy, oxo, amino groups and the radicals R 4 and R 5 independently of one another for a chemical bond to the Si atom or to one of the radicals R 1 , R 2 or R 3 , a hydrogen atom, a saturated or unsaturated, straight-chain, branched, or cyclic, substituted or unsubstituted hydrocarbon radical or for a substituted or unsubstituted SiIyI or alumino group or for a substituted or unsubstituted
  • R 1 , R 2 and R 3 in the abovementioned formula (VIII) are substituted or unsubstituted, straight-chain or branched alkyl radicals.
  • the alkyl groups having 1 to 5 carbon atoms and the hydroxyalkyl groups are preferred, so that preferred compositions are characterized in that the R 1 , R 2 and R 3 in formula (VIII) are selected from methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, terf-butyl and hydroxymethyl and hydroxyethyl radicals.
  • Preferred radicals R 4 and R 5 in the abovementioned formula (VIII) are hydrogen, substituted or unsubstituted, straight-chain or branched alkyl radicals and trialkylsilyl radicals. Among them, preferred are hydrogen, methyl, ethyl, tert-butyl and trimethylsilyl radicals.
  • compositions according to the invention preferably at least one compound selected from acetic acid, lactic acid, tartaric acid, citric acid, salicylic acid and ortho-phthalic acid may be contained.
  • Bleach amplifiers are preferably peroxo compounds.
  • the bleach-enhancing peroxy compounds according to the invention there are no addition products of hydrogen peroxide to other components and also not hydrogen peroxide itself.
  • the choice of peroxo compounds is subject to no restrictions.
  • Preferred peroxo compounds are peroxydisulfate salts, monopersulfate salts, (in particular ammonium peroxydisulfate, potassium peroxodisulfate, sodium peroxodisulfate, ammonium monopersulfate, potassium monopersulfate, sodium monopersulfate,
  • Potassium peroxide phosphate potassium peroxide phosphate
  • peroxides such as barium peroxide and magnesium peroxide
  • the inorganic compounds are preferred according to the invention.
  • Particularly preferred are the Peroxidisulfatsalze, in particular ammonium peroxydisulfate.
  • the bleach boosters are contained in the cosmetic compositions preferably in amounts of 5-30 wt .-%, in particular in amounts of 8-20 wt .-%.
  • the agents according to the invention preferably have a pH of from pH 2 to pH 11, in particular from pH 8 to pH 11.
  • a gel carrier is selected.
  • This gel carrier preferably contains 1, 0 to 15 wt .-% of a saturated or unsaturated, linear or branched alcohol having 8 to 36 carbon atoms,
  • a liquid fatty acid having 16 to 22 carbon atoms in the form of a water-soluble soap 0.1 to 15 wt .-% of a liquid fatty acid having 16 to 22 carbon atoms in the form of a water-soluble soap.
  • the saturated or unsaturated, linear or branched alcohols having 8 to 36 C atoms to be used according to the invention are preferably fatty alcohols and / or Guerbet alcohols.
  • Fatty alcohols are to be understood as meaning primary aliphatic alcohols of the formula (IX)
  • R 1 is an aliphatic, linear or branched hydrocarbon radical having 8 to 22 carbon atoms which is saturated or may contain up to 3 double bonds.
  • Typical examples are 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol, and technical mixtures thereof for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols.
  • Preference is given to technical fatty alcohol mixtures having 12 to 18 carbon atoms, for example coconut, palm, palm kernel or tallow fatty alcohol, in particular
  • Guerbet alcohols are to be understood as alcohols which are prepared by alkaline condensation of alcohols to higher molecular weight, branched iso alcohols. This implementation was first published by Guerbet in 1899. Machemer presented 1952 essential steps of the reaction (Angewandte Chemie 64 (1952) 213-20): In addition to the dehydrogenation to ketone, in which hydrogen is split off, and the aldol condensation is the crotonization, in which water is split off, an important step in the reaction process , The prior art is a reaction at atmospheric pressure and a reaction temperature of 240 to 260 0 C. The branched alcohols thus obtained are referred to as Guerbet alcohols. In the meantime, a large number of other processes are known from the prior art according to which Guerbet alcohols can be obtained.
  • Suitable adducts of 1 to 4 or 15 to 100 mol of ethylene oxide with a linear fatty alcohol having 12 to 22 carbon atoms are all adducts obtainable by the known industrial ethoxylation processes. Preference is given to the addition products which contain only a small amount of free fatty alcohol and have a narrow homolog distribution (so-called narrow-rank ethoxylates), as described, for example, in US Pat. are accessible according to the method described in DE 38 43 713 A1.
  • addition products of 15 to 100 moles of ethylene oxide, in particular from 15 to 50 moles of ethylene oxide, to a linear fatty alcohol having 8 to 22 carbon atoms in the gel compositions are very particularly preferably ceteareth-15 or ceteareth-50, which are marketed as Eumulgin ® CS 15 and CS Eumulgin ® 50 by Cognis Germany GmbH.
  • the fatty acids suitable for soap formation are preferably liquid or low-melting unsaturated linear fatty acids having 16 to 22 carbon atoms such as palmitoleic, oleic, elaidic, myristic, petroselic, petroselaidic, gadoleic, erucic, brassidic and mixtures of these fatty acids with each other and optionally with lower levels of saturated linear Fatty acids with 12 to 22 carbon atoms.
  • liquid or low-melting branched fatty acids are branched fatty acids having 16 to 22 carbon atoms, for example, the 2-hexyldecanoic acid, isostearic acid and 2-octyldodecanoic acid.
  • alkali metal hydroxides and alkali metal carbonates For the conversion of fatty acids into water-soluble soaps are alkali metal hydroxides and alkali metal carbonates, ammonia, mono-, di- and trialkanolamines having 2 to 4 carbon atoms in the alkanol group and alkaline amino acids such as arginine, ornithine, lysine and / or histidine.
  • adjusting the viscosity of the gelatinous composition additionally at least one low molecular weight, water-soluble monoalcohol, more preferably in an amount of 0.5 to 20 wt .-% based on the weight of the total composition to add.
  • low-molecular weight monoalcohols are to be understood as meaning water-miscible alcohols having 1 to 5 C atoms. These monoalcohols carry only one hydroxy group. It is preferably ethanol, propanol and / or isopropanol.
  • compositions according to the invention may additionally contain at least one polyol.
  • polyols carry at least two hydroxyl groups, preferably two to four hydroxy groups.
  • polyols especially those having 2 to 6 C atoms are preferred. It is suitable e.g. Ethylene glycol, 1, 2-propylene glycol, 1, 3-propylene glycol, glycerol, erythritol, trimethylolpropane, diethylene glycol and dipropylene glycol.
  • 1,2-Propylene glycol is particularly preferred.
  • Suitable water-soluble synthetic surfactants are preferably anionic, amphoteric, zwitterionic and nonionic surfactants having good water solubility and good lime soap dispersibility.
  • Such surfactants typically have a lipophilic linear alkyl or acyl group of 12 to 18 carbon atoms and a highly dissociated ionic group or nonionic water-solubilizing polyether group.
  • Suitable examples are sulfuric acid semi-salts of linear fatty alcohols having 12 to 18 carbon atoms or of fatty alcohol polyglycol ethers having 12 to 16 carbon atoms in the alkyl group and 1 to 10 glycol ether groups.
  • suitable anionic surfactants are, for example, linear alkanesulfonates and ⁇ -olefin sulfonates having 12 to 18 C atoms.
  • Suitable nonionic surfactants are, for example, the addition products of 5 to 14 moles of ethylene oxide with linear fatty alcohols having 12 to 18 carbon atoms, with fatty acids having 12 to 18 carbon atoms and with fatty acid monoglycerides and with fatty acid sorbitan monoesters.
  • suitable nonionic surfactants are the fatty alkylamine oxides and in particular the fatty alkyl glycosides, preferably fatty alkyl glucosides.
  • the fatty alkyl group may have 12 to 18 C atoms in the products mentioned.
  • amphoteric surfactants for example N-fatty-alkyl-dimethyl-glycine or N-fatty-alkylaminopropionic acid and / or zwitterionic surfactants, e.g. N-Fettalkyl- dimethylammoniumglycinat or N-Fettacylaminopropyldimethylglycinat.
  • cationic surfactants such as quaternary ammonium compounds (QACs), in particular quaternized trialkylammonium compounds with alkyl radicals having a chain length of C8 to C22.
  • the agents of the invention may contain addition products of from 1 to 4 moles of ethylene oxide onto a fatty alkylamine.
  • addition products of 1 to 4 moles of ethylene oxide to a linear fatty alkylamine having 12 to 22 carbon atoms are all accessible by known technical methods adducts, which are also commercially available. Particularly suitable is the adduct of 2 moles of ethylene oxide to a C 12 -
  • dialkyl ethers having 12 to 18 carbon atoms in the alkyl groups.
  • Such Dialkyloxyethyl ethers can be prepared from fatty alcohols and fatty alkoxyethanols by etherification processes known from the literature.
  • HO-C 2 H 4 -N is, for example, from triethanolamine by O-alkylation with 2 moles of a sulfuric acid half-salt of a win by the method described in DE 35 04 242 for the preparation of ether amines.
  • Particularly preferred compounds of formula X are e.g. Dicetylstearyl ether, dicetylstearyldioxyethyl ether and N, N-bis (2-cetyl / stearyl-oxyethyl) aminoethanol.
  • Xanthan gum, agar agar, linear and crosslinked polyacrylates, nonionic and anionic cellulose derivatives and amphiphilic polymers can be contained in the compositions according to the invention as additional thickeners.
  • the agents according to the invention may additionally contain at least one cationic polymer.
  • Cationic polymers are polymers which have groups in the main and / or side chain which may be "temporary" or “permanent” cationic.
  • permanently cationic such Denotes polymers which have a cationic group regardless of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • R 1 -H or -CH 3
  • R 2 , R 3 and R 4 are independently selected from C 1-4 alkyl, alkenyl or hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is a natural number
  • X is a physiologically acceptable organic or inorganic anion
  • copolymers consisting essentially of the monomer units listed in formula (XI) and nonionic monomer units are particularly preferred cationic polymers within the scope of these polymers, those are preferred according to the invention for which at least one of the following conditions applies:
  • R 1 is a methyl group - R 2 , R 3 and R 4 are methyl groups m is 2.
  • Suitable physiologically tolerated counterions X- include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preference is given to halide ions, in particular chloride.
  • a particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
  • the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylene bisacrylamide, diallyl ether, polyallyl polyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are available under the names Salcare ® SC 95 (about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth- 6)), and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene polyoxyethylene ether (INCI name: PPG-1-Trideceth-6)) commercially available.
  • Copolymers having monomer units of the formula (XI) contain, as nonionic monomer units, preferably acrylamide, methacrylamide, acrylic acid C 1-4 -alkyl esters and methacrylic acid-C 1. 4- alkyl esters. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, commercially available as about 50% non-aqueous polymer dispersion under the name Salcare ® SC 92nd
  • honey for example the commercial product Honeyquat ® 50,
  • Products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethyl silylamodimethicon), Dow Corning ® 929 Emulsion (containing a hydroxylamino-modified silicone which is also known as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th Goldschmidt; diquaternary polydimethylsiloxanes, quaternium-80).
  • Such compounds are available under the names Gafquat ® 734 and Gafquat ® 755 commercially, vinylpyrrolidone-vinyl imidazolium copolymers, such as those offered under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as the under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and
  • Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.
  • cationic polymers can be used as cationic polymers (. B. commercial product, Quatrisoft ® LM 200) under the designations Polyquaternium-24, known polymers. Also usable in the invention are the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ® VC 713 (manufactured by ISP), Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
  • Other cationic polymers of the invention are the "temporarily cationic" polymers.
  • polymers usually contain an amino group present at certain pH values as a quaternary ammonium group and thus cationic are preferred, for example, chitosan and its derivatives, such as, for example, under the trade designations Hydagen ®. , Hydagen® ® HCMF, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially CMF.
  • chitosans are deacetylated, in different degrees of deacetylation and varying degrees of degradation (molecular weights) are commercially available. Their preparation is, for example, in DE 44 40 625 A1 and described in DE 1 95 03 465 A1.
  • Particularly useful chitosans have a degree of deacetylation of at least 80% and a molecular weight of 5 ⁇ 10 5 to 5 • 10 6 (g / mol).
  • the chitosan must be converted into the salt form. This can be done by dissolving in dilute aqueous acids.
  • acids both mineral acids, e.g. Hydrochloric acid, sulfuric acid and phosphoric acid as well as organic acids, e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids suitable.
  • organic acids e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids suitable.
  • Organophosphoric acids are used, provided that they have the required physiological compatibility.
  • Suitable acids for converting the chitosan into the salt form are e.g. Acetic acid, glycolic acid, tartaric acid, malic acid, citric acid, lactic acid, 2-pyrrolidinone-5-carboxylic acid, benzoic acid or salicylic acid.
  • Preferred are low molecular weight hydroxycarboxylic acids such as e.g. Glycolic acid or lactic acid.
  • hair cosmetic auxiliaries may be contained, in particular bisabolol, plant extracts, vitamins such as preferably niacinamide, tocopherol, vitamin A, vitamin B 6 , biotin and vitamin D.
  • a preferred embodiment of the first subject of the invention is an oxidative hair dye. This is immediately before use by mixing an oxidizing agent preparation comprising in a cosmetic carrier at least one oxidizing agent having a composition comprising in a (preferably gel) cosmetic carrier (i) ginseng extract as well
  • the resulting ready-to-use hair dye preparation should preferably have a pH in the range from 6 to 12, in particular from 8 to 11. Particularly preferred is the use of the hair dye in a weakly alkaline medium.
  • the application temperatures can be in a range between 15 and 40 0 C.
  • the hair dye is removed by rinsing of the hair to be dyed. The washing with a shampoo is omitted if a strong surfactant-containing carrier, such as a dyeing shampoo was used.
  • the oxidizing agent preparation particularly preferably contains
  • aqueous carrier in addition to the usual stabilizing aids in such preparations.
  • stabilizing aids in such preparations.
  • it can also consist in the simplest case of water alone, so that the oxidation is brought about by the atmospheric oxygen.
  • the water-soluble synthetic surfactants which may be used in the oxidizing agent preparation are the anionic, amphoteric, zwitterionic and nonionic surfactants already mentioned for the carrier composition of the invention or mixtures thereof.
  • anionic surfactants for example sulfuric monoester salts of linear fatty alcohols having 12 to 18 carbon atoms or of fatty alcohol polyglycol ethers having 12 to 16 carbon atoms in the alkyl group and 1 to 10 glycol ether groups in the form of their alkali metal, magnesium, ammonium or alkanolammonium salts used.
  • the oxidizing agent preparation also preferably contains complexing agents and buffer salts for adjusting a pH of from 2 to 5.
  • the acrylic acid and / or methacrylic acid polymer dispersions remain highly fluid and stable.
  • the alkaline carrier medium according to the invention which contains ammonia and buffer salts to set a pH of 8 to 10
  • the pH of the mixture increases and the carboxyl groups of the polymer or copolymer are converted into the salt form.
  • the polymers begin to dissolve in the aqueous medium and raise the viscosity of the solution.
  • the content of dispersed acrylic acid and / or methacrylic acid polymer or copolymer in the oxidizing agent preparation is particularly favorable for the viscosity build-up after mixing of the composition according to the invention and of the oxidizing agent preparation.
  • Such dispersions of copolymers for example from at least 10% by weight of acrylic acid lower alkyl ester, from 25 to 70% by weight of methacrylic acid and optionally up to 40% by weight of a further comonomer, are described, for example, in GB 870 994. From DE 11 64 095, copolymers of 50 to 75% by weight of ethyl acrylate, 25 to 35% by weight of acrylic acid and 0 to 25% by weight of other comonomers are known.
  • Suitable dispersions of this type are commercially available, for example under the trade name Latekoll D ® (BASF). Particularly suitable are the copolymers described in DE 34 45 549 from 50 to 60 wt .-% ethyl acrylate, 30 to 40 wt .-% methacrylic acid and 5 to 15 wt .-% acrylic acid, crosslinked with ethylene glycol dimethacrylate.
  • BASF Latekoll D ®
  • a second subject of the invention is the use of a cosmetic agent of the first subject of the invention for reducing oxidative-induced skin irritation during oxidative hair treatment.
  • a third subject of the invention is the use of a cosmetic agent of the first subject of the invention for reducing oxidative-induced skin elasticity impairment during the oxidative hair treatment.
  • a fourth subject of the invention is the use of a cosmetic agent of the first subject of the invention for reducing the oxidizing agent induced impairment of hair conditioning during oxidative hair treatment.
  • the moisture balance of the hair is improved by the use of ginseng extract according to the invention, so that the hair is less brittle.
  • a fifth subject of the invention is a method for treating keratin-containing fibers, in particular human hair, in which a cosmetic product of the first subject of the invention is applied to the hair and rinsed off again after a contact time.
  • human hair strands from Kerling (Nuance 8-0, dark blonde, weight 2.0 g, length 11 cm) were first washed with 30 ml of Texapon NSO UP, rinsed with water and dried in the air for 24 hours and then conditioned for 24 hours at 25 0 C and a relative humidity of 40%.
  • the zero value measurement of the moisture in the test hair strand is carried out according to the microwave method ⁇ vide infra).
  • Ci 2 -C 14 fatty alcohol with 2 units of ethylene oxide (INCI name: Laureth-2) (manufacturer: COGNIS)
  • Dye carrier V1 was used to obtain a colorant not according to the invention which was compared with the colorant of the invention obtained by using dye carrier E1.
  • the application mixture was applied in each case in the liquor ratio of 1.0 g of hair to 2.0 g of dye on the hair strand. After a reaction time of 5 minutes, the application mixture was rinsed from the hair strand with running 30 0 C warm water.
  • the rinsed hair was air dried for 24 hours and then conditioned for 24 hours at 25 0 C and a relative humidity of 40%. Subsequently, the moisture content of the treated hair strands was determined by the microwave method (vide infra). The moisture in the hair after treatment is calculated from the measurements as follows:
  • Moisture [in%] (average Fe UCHT lg ke ⁇ tdes treated hair / mean Nu
  • the hairs treated with the colorant according to the invention had a higher moisture content with a humidity of 109.0% than the hair treated with the reference colorant (106.8).
  • the strand of hair to be measured is introduced into the measuring tube of the measuring device. There are five measurement points per hair strand. The measured value of the moisture of the measuring hair strand is calculated as the arithmetic mean of the individual measured values of these five measuring points.
  • Ci 2 -Ci 4 fatty alcohol with 2 units of ethylene oxide (INCI name: Laureth-2) (manufacturer: COGNIS)
  • a dye carrier according to Table 3 was mixed with the oxidizer preparation according to Table 2 (vide supra) in a weight ratio of 4 to 5 to give a ready-to-use gel colorant.

Abstract

La présente invention concerne des compositions stables à l'oxydation qui, outre au moins un agent oxydant, contiennent également un extrait de ginseng, le tout dans un support cosmétique. Ces compositions servent à réduire l'altération des cheveux, le vieillissement de la peau et l'irritation cutanée induits par l'agent oxydant et à améliorer l'élasticité de la peau. Les effets de l'extrait peuvent déjà être obtenus pendant le traitement capillaire oxydant, en présence d'un agent oxydant.
PCT/EP2007/000662 2006-02-07 2007-01-26 Agent de traitement capillaire oxydant comprenant un extrait de ginseng WO2007090527A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07703051A EP1986592A2 (fr) 2006-02-07 2007-01-26 Agent de traitement capillaire oxydant comprenant un extrait de ginseng

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006005767A DE102006005767A1 (de) 2006-02-07 2006-02-07 Oxidative Haarbehandlungsmittel mit Ginsengextrakt
DE102006005767.8 2006-02-07

Publications (2)

Publication Number Publication Date
WO2007090527A2 true WO2007090527A2 (fr) 2007-08-16
WO2007090527A3 WO2007090527A3 (fr) 2007-10-11

Family

ID=38198395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/000662 WO2007090527A2 (fr) 2006-02-07 2007-01-26 Agent de traitement capillaire oxydant comprenant un extrait de ginseng

Country Status (3)

Country Link
EP (1) EP1986592A2 (fr)
DE (1) DE102006005767A1 (fr)
WO (1) WO2007090527A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010072577A2 (fr) * 2008-12-15 2010-07-01 Henkel Ag & Co. Kgaa Agent de coloration pour soins capillaires
JP2018012724A (ja) * 2008-11-10 2018-01-25 アルブータス・バイオファーマー・コーポレイション 治療薬を送達するための新規な脂質及び組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007001008A1 (de) * 2007-01-02 2008-07-03 Henkel Kgaa Kosmetische Wirkstoffzusammensetzung mit Ayurveda-Extrakten
FR2953135B1 (fr) 2009-11-30 2012-05-11 Expanscience Lab Extrait de graines d'acacia macrostachya et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126429A1 (de) * 1991-08-09 1993-02-11 Hartmann Haarkosmetik Gmbh Persulfat-haltiges haarblondierungsmittel mit persulfat-stabilisierender und in gebrauchsfertiger michung wirkungsfoerdernder sowie gegen haarversproedung wirkender komponente
WO1999007338A1 (fr) * 1997-08-08 1999-02-18 Lvmh Recherche UTILISATION DU GINSENOSIDE Rb1 POUR STIMULER LA SYNTHESE DE L'ELASTINE
EP0919220A2 (fr) * 1997-11-06 1999-06-02 Joseph Lizzi Produit pour le traitement des cheveux et de la peau contenant un extrait d'aloé vera
WO2000064279A1 (fr) * 1999-04-23 2000-11-02 E Excel International Inc. Produits de sante obtenus a partir du fruit du cactus
EP1327434A1 (fr) * 2002-01-05 2003-07-16 Pacific Corporation Nanoemulsion comprenant des derives de ginseng saponines et composition pour le traitement des signes cutanes du vieillissement comprenant cette nanoemulsion
EP1382341A1 (fr) * 2002-07-18 2004-01-21 Cognis Iberia, S.L. Utilisation de compositions comprenant l'acide glycyrrhetinique et peroxyde de benzoyle pour le traitement de l'acné
EP1400237A2 (fr) * 2002-09-06 2004-03-24 L'oreal Utilisation d'un activateur de protectin pour améliorer la résistance de la peau
DE10315421A1 (de) * 2003-04-03 2004-10-14 Henkel Kgaa Leistungsfähige oxidative Haarbehandlungsmittel mit Faserstrukturstabilisierung durch Radikalfänger
WO2005058314A2 (fr) * 2003-12-18 2005-06-30 Unilever Plc Methodes permettant de reduire les effets du stress sur l'etat de la peau
WO2005123021A1 (fr) * 2004-06-22 2005-12-29 Henkel Kommanditgesellschaft Auf Aktien Agents blondissant les cheveux, renfermant des derives d'acide carbonique
WO2006001654A1 (fr) * 2004-06-29 2006-01-05 Hongrim Trading Co., Ltd. Composition contenant de l'extrait de ginseng comprenant des derives de saponine isoles du radix ginseng et ginseng utilise pour empecher et traiter les maladies induites par les griffures
JP2007008896A (ja) * 2005-07-04 2007-01-18 Shoyaku Hakko Kenkyusho:Kk 皮膚外用消炎鎮痛剤並びにその製造法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005306806A (ja) * 2004-04-23 2005-11-04 Nikko Chemical Co Ltd コラーゲン合成促進剤及び抗老化用化粧料

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126429A1 (de) * 1991-08-09 1993-02-11 Hartmann Haarkosmetik Gmbh Persulfat-haltiges haarblondierungsmittel mit persulfat-stabilisierender und in gebrauchsfertiger michung wirkungsfoerdernder sowie gegen haarversproedung wirkender komponente
WO1999007338A1 (fr) * 1997-08-08 1999-02-18 Lvmh Recherche UTILISATION DU GINSENOSIDE Rb1 POUR STIMULER LA SYNTHESE DE L'ELASTINE
EP0919220A2 (fr) * 1997-11-06 1999-06-02 Joseph Lizzi Produit pour le traitement des cheveux et de la peau contenant un extrait d'aloé vera
WO2000064279A1 (fr) * 1999-04-23 2000-11-02 E Excel International Inc. Produits de sante obtenus a partir du fruit du cactus
EP1327434A1 (fr) * 2002-01-05 2003-07-16 Pacific Corporation Nanoemulsion comprenant des derives de ginseng saponines et composition pour le traitement des signes cutanes du vieillissement comprenant cette nanoemulsion
EP1382341A1 (fr) * 2002-07-18 2004-01-21 Cognis Iberia, S.L. Utilisation de compositions comprenant l'acide glycyrrhetinique et peroxyde de benzoyle pour le traitement de l'acné
EP1400237A2 (fr) * 2002-09-06 2004-03-24 L'oreal Utilisation d'un activateur de protectin pour améliorer la résistance de la peau
DE10315421A1 (de) * 2003-04-03 2004-10-14 Henkel Kgaa Leistungsfähige oxidative Haarbehandlungsmittel mit Faserstrukturstabilisierung durch Radikalfänger
WO2005058314A2 (fr) * 2003-12-18 2005-06-30 Unilever Plc Methodes permettant de reduire les effets du stress sur l'etat de la peau
WO2005123021A1 (fr) * 2004-06-22 2005-12-29 Henkel Kommanditgesellschaft Auf Aktien Agents blondissant les cheveux, renfermant des derives d'acide carbonique
WO2006001654A1 (fr) * 2004-06-29 2006-01-05 Hongrim Trading Co., Ltd. Composition contenant de l'extrait de ginseng comprenant des derives de saponine isoles du radix ginseng et ginseng utilise pour empecher et traiter les maladies induites par les griffures
JP2007008896A (ja) * 2005-07-04 2007-01-18 Shoyaku Hakko Kenkyusho:Kk 皮膚外用消炎鎮痛剤並びにその製造法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200578 Derwent Publications Ltd., London, GB; AN 2005-763109 XP002443433 & JP 2005 306806 A (COSMOS TECH CENT) 4. November 2005 (2005-11-04) *
JOHN C. CHANG: "Ginseng and Cosmetics" COSMETICS AND TOILETRIES, Bd. 92, Mai 1977 (1977-05), Seiten 50-57, XP009086457 *
KIM C K K ET AL: "EFFECT OF GINSENG SAPONIN ON HAIR" COSMETICS & TOILETRIES, WHEATON, IL, US, Bd. 94, Nr. 10, Oktober 1979 (1979-10), Seiten 49-50,52,56,6, XP001059461 ISSN: 0361-4387 *
KIM S ET AL: "Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin" BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, Bd. 316, Nr. 2, 2. April 2004 (2004-04-02), Seiten 348-355, XP004495890 ISSN: 0006-291X *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018012724A (ja) * 2008-11-10 2018-01-25 アルブータス・バイオファーマー・コーポレイション 治療薬を送達するための新規な脂質及び組成物
US10821186B2 (en) 2008-11-10 2020-11-03 Arbutus Biopharma Corporation Lipids and compositions for the delivery of therapeutics
WO2010072577A2 (fr) * 2008-12-15 2010-07-01 Henkel Ag & Co. Kgaa Agent de coloration pour soins capillaires
WO2010072577A3 (fr) * 2008-12-15 2010-12-02 Henkel Ag & Co. Kgaa Agent de coloration pour soins capillaires

Also Published As

Publication number Publication date
WO2007090527A3 (fr) 2007-10-11
DE102006005767A1 (de) 2007-08-09
EP1986592A2 (fr) 2008-11-05

Similar Documents

Publication Publication Date Title
WO2005051336A1 (fr) Procede de coloration de fibres keratiniques
EP1800654B1 (fr) Réduction des signes de vieillesse des cheveux
WO2009047022A1 (fr) Traitement capillaire oxydant avec altération réduite des cheveux
EP1779894A1 (fr) Compositions de coloration capillaire
EP1986596A1 (fr) Traitement oxydatif du cheveu calmant pour la peau
EP1789015A1 (fr) Procede pour changer la couleur de fibres keratiniques selon la mode
EP1923048B1 (fr) Traitement capillaire en vue de la réduction de l'endommagement des cheveux
EP1945180A1 (fr) Emulsions pit detergentes
DE102007041492A1 (de) Blondiermittel mit verzögertem Bleichbeginn
EP2054123B1 (fr) Coloration capillaire protectrice pour la peau
EP1986592A2 (fr) Agent de traitement capillaire oxydant comprenant un extrait de ginseng
WO2008028895A1 (fr) Diminution du vieillissement capillaire
EP1792951A2 (fr) Pigments mélaniques biomimétiques
EP1776984A2 (fr) Méthode pour prolonger les cycles de recoloration
EP1948125B1 (fr) Agent de traitement capillaire volumisant
EP1759735B1 (fr) Méthode pour la coloration sélective des cheveux
DE102006005450A1 (de) Haar-Colorationscreme auf Polymerbasis
EP1909913A1 (fr) Procede pour dissimuler rapidement des racines capillaires resultant de la pousse de cheveux colores
DE10343235A1 (de) Mittel zur Verminderung der Kopfhautanfärbung bei Haarfärbeprozessen
DE10343236A1 (de) Mittel zur Verminderung der Kopfhautanfärbung
EP1962789A1 (fr) Produit capillaire volumisant
DE102006020246A1 (de) Dialkylketonperoxide als effektive Oxidationsmittel in der Haarbehandlung

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007703051

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE